OTHER · Unmapped registry intervention
Fasting therapy
Find medicine records ·
Find other trials using this name
Clinical trial
Effect of Fasting Therapy on Blood Glucose Control and Islet Function in Newly Diagnosed Type 2 Diabetic Patients
NCT02956655
Drugs and interventions used in this trial
5 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Insulin intensive therapy: Human Insulin (Novolin-R, Novo Nordisk)
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
Exercise
Find medicine records ·
Find other trials using this name
BEHAVIORAL · Unmapped registry intervention
Lifestyle guidance
Find medicine records ·
Find other trials using this name
DEVICE · Unmapped registry intervention
H-Tron Plus V100; Disetronic Medical System, Burgdorf, Switzerland
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEffect of Fasting Therapy on Blood Glucose Control and Islet Function in Newly Diagnosed Type 2 Diabetic Patients
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sponsors & collaborators
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02956655 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.